Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2002 | 2009 | |||||||||
|
dendritic cell associated nuclear protein | 0.839 | 0.154 |
|
disease | 0.320 | None | 0.667 | 3 | 0 | 2010 | 2013 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2010 | 2012 | |||||||||
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2019 | |||||||||
|
microRNA 1202 | 0.729 | 0.385 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2017 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
microRNA 30e | 0.576 | 0.769 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
thyroglobulin | 0.480 | 0.808 | 2.9E-59 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
pericentrin | 0.564 | 0.808 | 4.0E-58 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2009 | 2010 | ||||||||
|
cardiomyopathy associated 5 | 0.711 | 0.423 | 1.3E-54 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
multiple C2 and transmembrane domain containing 2 | 0.623 | 0.577 | 6.0E-52 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
phosphodiesterase 11A | 0.612 | 0.654 | 8.7E-37 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 1 | 0.691 | 0.462 | 2.1E-31 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ATPase copper transporting beta | 0.529 | 0.654 | 4.8E-30 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
glutamyl aminopeptidase | 0.564 | 0.731 | 1.4E-28 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.380 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
matrix metallopeptidase 8 | 0.488 | 0.808 | 1.1E-24 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
2'-5'-oligoadenylate synthetase 2 | 0.670 | 0.538 | 2.6E-21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 1996 | 2018 | ||||||||
|
FRAS1 related extracellular matrix 3 | 0.805 | 0.269 | 1.5E-19 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2012 | 2019 |